JP2007529714A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529714A5
JP2007529714A5 JP2007502088A JP2007502088A JP2007529714A5 JP 2007529714 A5 JP2007529714 A5 JP 2007529714A5 JP 2007502088 A JP2007502088 A JP 2007502088A JP 2007502088 A JP2007502088 A JP 2007502088A JP 2007529714 A5 JP2007529714 A5 JP 2007529714A5
Authority
JP
Japan
Prior art keywords
score
group
individual
allele
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007502088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007529714A (ja
Filing date
Publication date
Priority claimed from US10/956,224 external-priority patent/US7127355B2/en
Application filed filed Critical
Publication of JP2007529714A publication Critical patent/JP2007529714A/ja
Publication of JP2007529714A5 publication Critical patent/JP2007529714A5/ja
Withdrawn legal-status Critical Current

Links

JP2007502088A 2004-03-05 2005-03-03 遺伝子分析のための方法 Withdrawn JP2007529714A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55066204P 2004-03-05 2004-03-05
US56630204P 2004-04-28 2004-04-28
US59053404P 2004-07-22 2004-07-22
US10/956,224 US7127355B2 (en) 2004-03-05 2004-09-30 Methods for genetic analysis
PCT/US2005/007375 WO2005086770A2 (en) 2004-03-05 2005-03-03 Methods for genetic analysis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013151528A Division JP2013240344A (ja) 2004-03-05 2013-07-22 遺伝子分析のための方法

Publications (2)

Publication Number Publication Date
JP2007529714A JP2007529714A (ja) 2007-10-25
JP2007529714A5 true JP2007529714A5 (https=) 2008-04-17

Family

ID=34916521

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007502088A Withdrawn JP2007529714A (ja) 2004-03-05 2005-03-03 遺伝子分析のための方法
JP2013151528A Pending JP2013240344A (ja) 2004-03-05 2013-07-22 遺伝子分析のための方法
JP2016016966A Pending JP2016082984A (ja) 2004-03-05 2016-02-01 遺伝子分析のための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013151528A Pending JP2013240344A (ja) 2004-03-05 2013-07-22 遺伝子分析のための方法
JP2016016966A Pending JP2016082984A (ja) 2004-03-05 2016-02-01 遺伝子分析のための方法

Country Status (4)

Country Link
US (2) US7127355B2 (https=)
EP (1) EP1725967A4 (https=)
JP (3) JP2007529714A (https=)
WO (1) WO2005086770A2 (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7127355B2 (en) * 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
US20090087854A1 (en) * 2007-09-27 2009-04-02 Perlegen Sciences, Inc. Methods for genetic analysis
US20060166224A1 (en) * 2005-01-24 2006-07-27 Norviel Vernon A Associations using genotypes and phenotypes
US7421419B2 (en) * 2005-04-12 2008-09-02 Viziant Corporation System and method for evidence accumulation and hypothesis generation
CA2631621C (en) * 2005-11-29 2019-08-06 Cambridge Enterprise Limited Markers for breast cancer including rs2981582
MX2008011185A (es) * 2006-03-01 2008-09-10 Perlegen Sciences Inc Marcadores para adiccion.
US20110143344A1 (en) * 2006-03-01 2011-06-16 The Washington University Genetic polymorphisms and substance dependence
US9115389B2 (en) 2006-06-30 2015-08-25 Rosetta Genomics Ltd. Method for detecting a target nucleic acid comprising two portions using probes having a first portion complementary to the first portion of the target nucleic acid and a second portion substantially complementary to the second portion of the target nucleic acid
SI2084535T1 (sl) * 2006-09-08 2016-08-31 Richard Porwancher Postopek diagnosticiranja s pomočjo bioinformatike
US20080131887A1 (en) * 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
JP2010522537A (ja) * 2006-11-30 2010-07-08 ナビジェニクス インコーポレイティド 遺伝子分析系および方法
US20080228700A1 (en) 2007-03-16 2008-09-18 Expanse Networks, Inc. Attribute Combination Discovery
US20090012839A1 (en) * 2007-07-03 2009-01-08 American Express Travel Related Services Company, Inc. Determining Brand Affiliations
US20090043752A1 (en) 2007-08-08 2009-02-12 Expanse Networks, Inc. Predicting Side Effect Attributes
CA2700975A1 (en) * 2007-09-26 2009-04-02 Navigenics, Inc. Methods and systems for genomic analysis using ancestral data
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
US20090326832A1 (en) * 2008-06-27 2009-12-31 Microsoft Corporation Graphical models for the analysis of genome-wide associations
GB2478065A (en) * 2008-08-08 2011-08-24 Navigenics Inc Method and systems for personalized action plans
US8200509B2 (en) 2008-09-10 2012-06-12 Expanse Networks, Inc. Masked data record access
US7917438B2 (en) * 2008-09-10 2011-03-29 Expanse Networks, Inc. System for secure mobile healthcare selection
KR20110074527A (ko) * 2008-09-12 2011-06-30 네이비제닉스 인크. 복수의 환경 및 유전 위험 인자를 통합하기 위한 방법 및 시스템
US8255403B2 (en) 2008-12-30 2012-08-28 Expanse Networks, Inc. Pangenetic web satisfaction prediction system
US8386519B2 (en) 2008-12-30 2013-02-26 Expanse Networks, Inc. Pangenetic web item recommendation system
US8108406B2 (en) * 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
US20100169338A1 (en) * 2008-12-30 2010-07-01 Expanse Networks, Inc. Pangenetic Web Search System
US8463554B2 (en) 2008-12-31 2013-06-11 23Andme, Inc. Finding relatives in a database
US20120323600A1 (en) * 2009-05-07 2012-12-20 Pathway Genomics Genome-based drug management systems
US20110294681A1 (en) 2009-06-01 2011-12-01 Hinds David A Methods for breast cancer risk assessment
EP2482810A2 (en) * 2009-09-29 2012-08-08 Novartis AG Dosage regimen of an s1p receptor modulator
WO2012031207A2 (en) 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
DK2635704T3 (en) * 2010-11-01 2017-06-19 Hoffmann La Roche Predicting progression to advanced age-related macular degeneration using a polygenic score
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
US20130218581A1 (en) * 2011-04-26 2013-08-22 Selventa, Inc. Stratifying patient populations through characterization of disease-driving signaling
US20140378351A1 (en) * 2013-06-22 2014-12-25 Brian Meshkin System and method for processing genotype information relating to treatment with pain medication
AU2014306867B2 (en) 2013-08-12 2017-10-26 Genentech, Inc. Compositions and method for treating complement-associated conditions
EP3137503A1 (en) 2014-05-01 2017-03-08 Genentech, Inc. Anti-factor d antibody variants and uses thereof
EP3194627B1 (en) * 2014-09-18 2023-08-16 Illumina, Inc. Methods and systems for analyzing nucleic acid sequencing data
US10920279B2 (en) 2014-09-30 2021-02-16 Genetic Technologies Limited Method for modifying a treatment regimen of a human female subject
EP3543361A1 (en) * 2014-10-14 2019-09-25 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with colorectal cancer risk
US10152298B1 (en) * 2015-06-29 2018-12-11 Amazon Technologies, Inc. Confidence estimation based on frequency
WO2017075252A1 (en) 2015-10-30 2017-05-04 Genentech, Inc. Anti-factor d antibody variant conjugates and uses thereof
US10407510B2 (en) 2015-10-30 2019-09-10 Genentech, Inc. Anti-factor D antibodies and conjugates
IL260777B (en) 2016-01-28 2022-09-01 Univ Melbourne Methods for assessing risk of developing colorectal cancer
US20170240965A1 (en) * 2016-02-22 2017-08-24 Cedars-Sinai Medical Center Methods for prognosing heart transplant
US10783997B2 (en) 2016-08-26 2020-09-22 International Business Machines Corporation Personalized tolerance prediction of adverse drug events
RU2678441C1 (ru) * 2018-07-02 2019-01-29 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития гипертонической болезни с учетом генетических и средовых факторов
EP4158067A4 (en) 2020-05-27 2024-09-25 Genetic Technologies Limited Methods of assessing risk of developing a severe response to coronavirus infection
MX2023002925A (es) * 2020-09-10 2023-09-29 Microgenesis Corp Metodos y composiciones relacionados con la evaluacion de afecciones inflamatorias relacionadas con la fecundidad.
WO2022080389A1 (ja) * 2020-10-14 2022-04-21 Ｃｒａｉｆ株式会社 観測値の確からしさを評価する方法、及びプログラム
US20250149176A1 (en) * 2023-11-08 2025-05-08 Optum Services (Ireland) Limited Model-based risk prediction and treatment pathway prioritization

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023A (en) * 1843-03-30 peters
US20020048749A1 (en) 1998-04-15 2002-04-25 Robert J. Lipshutz Methods for polymorphism identifcation and profiling
US5968770A (en) 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
US6274332B1 (en) 1995-12-22 2001-08-14 Univ. Of Utah Research Foundation Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
US5817461A (en) 1996-01-03 1998-10-06 Hamilton Civic Hospitals Research Development Inc. Methods and compositions for diagnosis of hyperhomocysteinemia
ES2229781T3 (es) 1998-11-10 2005-04-16 Genset Metodos programas y aparatos para identificar regiones genomicas que albergan un gen asociado con un rasgo detectable.
US20040171056A1 (en) 1999-02-22 2004-09-02 Variagenics, Inc., A Delaware Corporation Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
JP2003521024A (ja) 1999-06-25 2003-07-08 ジェネサンス・ファーマシューティカルズ・インコーポレーテッド ハプロタイプデータの入手および使用のための方法
US20020077756A1 (en) * 1999-11-29 2002-06-20 Scott Arouh Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including drug dosage estimation
AU2001231091A1 (en) * 2000-01-21 2001-07-31 Vincent P. Stanton Jr. Identification of genetic components of drug response
US6931326B1 (en) * 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
WO2002016643A2 (en) * 2000-08-18 2002-02-28 Curagen Corporation Dna pooling methods for quantitative traits using unrelated populations or sib pairs
US20020098498A1 (en) 2000-09-29 2002-07-25 Bader Joel S. Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents
US6828103B2 (en) 2001-02-22 2004-12-07 Wake Forest University Genetic polymorphisms of estrogen receptor alpha associated with favorable response to hormone replacement therapy
AU2002322775A1 (en) 2001-07-27 2003-02-17 The Regents Of The University Of California Stk15 (stk6) gene polymorphism and methods of determining cancer risk
US20040086886A1 (en) 2001-09-11 2004-05-06 Goldstein Steven A.N. Polymorphisms associated with cardiac arrythmia
US20030162207A1 (en) * 2001-12-14 2003-08-28 Comings David E. Multi-gene tests with ROC plots for the assessment of risk for polygenic disorders
WO2003060652A2 (en) * 2002-01-15 2003-07-24 Vanderbilt University Method and apparatus for multifactor dimensionality reduction
US20030232398A1 (en) * 2002-03-28 2003-12-18 Macmurray James P. Use of ROC plots of genetic risk factor to predict risk of sporadic breast cancer
US20040115701A1 (en) 2002-08-30 2004-06-17 Comings David E Method for risk assessment for polygenic disorders
US20050118117A1 (en) 2002-11-06 2005-06-02 Roth Richard B. Methods for identifying risk of melanoma and treatments thereof
US20050032066A1 (en) 2003-08-04 2005-02-10 Heng Chew Kiat Method for assessing risk of diseases with multiple contributing factors
US20050037366A1 (en) 2003-08-14 2005-02-17 Joseph Gut Individual drug safety
US7470513B2 (en) 2003-11-10 2008-12-30 Academia Sinica Risk assessment for adverse drug reactions
US7127355B2 (en) * 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis

Similar Documents

Publication Publication Date Title
JP2007529714A5 (https=)
Zhou et al. Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Hubner et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease
Voight et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits
Stranger et al. Patterns of cis regulatory variation in diverse human populations
US20200027557A1 (en) Multimodal modeling systems and methods for predicting and managing dementia risk for individuals
Guo et al. Exome sequencing generates high quality data in non-target regions
Zhang et al. SNPdetector: a software tool for sensitive and accurate SNP detection
Ebbert et al. Population-based analysis of Alzheimer’s disease risk alleles implicates genetic interactions
Yang et al. Comparison of genome sequencing and clinical genotyping for pharmacogenes
Schadt et al. A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets
Shahwan et al. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population
Daya et al. Using multi-way admixture mapping to elucidate TB susceptibility in the South African Coloured population
WO2004049234A1 (ja) 疾患感受性遺伝子の同定方法
KR102303638B1 (ko) 알츠하이머성 치매가 발병될 가능성 평가방법
US20220367063A1 (en) Polygenic risk score for in vitro fertilization
Pat et al. Motivation and cognitive abilities as mediators between polygenic scores and psychopathology in children
Simonin-Wilmer et al. An overview of strategies for detecting genotype-phenotype associations across ancestrally diverse populations
Jeff et al. Admixture mapping and subsequent fine-mapping suggests a biologically relevant and novel association on chromosome 11 for type 2 diabetes in African Americans
Guelly et al. Patients with coronary heart disease, dilated cardiomyopathy and idiopathic ventricular tachycardia share overlapping patterns of pathogenic variation in cardiac risk genes
Weisburd et al. Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing data sets
Yu et al. Detecting natural selection by empirical comparison to random regions of the genome
JP2019524115A (ja) 気分障害検査用バイオマーカーとしてのｒｎａ編集
Im et al. A population-specific low-frequency variant of SLC22A12 (p. W258*) explains nearby genome-wide association signals for serum uric acid concentrations among Koreans
CN102947466B (zh) 肌醇聚磷酸盐-4-磷酸酶-类型2-基因(INPP4b-基因)中的人类染色体4的单核苷酸多形性用于多发硬化症的诊断或者预诊断